Wednesday, August 20, 2025 | 08:27 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Cholesterol

Merck's potential cholesterol pill succeeds in late-stage studies

The company is searching for its next blockbuster candidate as its major revenue driver, Keytruda, is expected to lose patent protection by the end of the decade

Merck's potential cholesterol pill succeeds in late-stage studies
Updated On : 09 Jun 2025 | 7:07 PM IST

India's oil intake has tripled-how much is too much for your health?

India's per capita oil intake has jumped to 23.5 kg a year-nearly twice the ICMR's limit-raising health concerns over obesity, heart disease, and diabetes

India's oil intake has tripled-how much is too much for your health?
Updated On : 23 Apr 2025 | 1:50 PM IST

Honey can lower risk of cardiometabolic disorder, researchers reveal

Researchers from the University of Toronto have discovered that honey can improve critical cardiometabolic health indicators including blood sugar and cholesterol levels

Honey can lower risk of cardiometabolic disorder, researchers reveal
Updated On : 20 Nov 2022 | 4:23 PM IST

Cholesterol drugs reduce risk of degenerative eye disease of ageing: Study

The findings of the study that was published online in the British Journal of Ophthalmology

Cholesterol drugs reduce risk of degenerative eye disease of ageing: Study
Updated On : 12 Nov 2022 | 5:56 PM IST

A panoramic history of the cell

Pulitzer Prize winner Siddhartha Mukherjee's The Song of The Cell is a beautifully crafted exposition of the author's own lifelong fascination with the subject

A panoramic history of the cell
Updated On : 10 Nov 2022 | 1:08 AM IST

A first in India: Zydus brings new drug for uncontrolled 'bad' cholesterol

Uncontrolled LDL-c, which poses a major risk of cardiovascular diseases, lacked proper treatment despite patients' lifestyle changes and use of statins

A first in India: Zydus brings new drug for uncontrolled 'bad' cholesterol
Updated On : 14 May 2022 | 12:04 AM IST

AstraZeneca sells cholesterol drug rights to Grünenthal for $320 million

AstraZeneca aims to streaming its businesses to focus on its cancer portfolio.

AstraZeneca sells cholesterol drug rights to Grünenthal for $320 million
Updated On : 01 Dec 2020 | 2:34 PM IST

Everyone has heard of the 'bad' cholesterol, but what's 'good' cholesterol?

Both genetics and the lifestyle play an important role in your cholesterol levels

Everyone has heard of the 'bad' cholesterol, but what's 'good' cholesterol?
Updated On : 15 Sep 2018 | 10:03 PM IST